Artelo Biosciences Inc. [NASDAQ: ARTL] gained 10.14% on the last trading session, reaching $1.52 price per share at the time. Artelo Biosciences Inc. represents 3.43 million in outstanding shares, while the company has a total market value of $5.06 million with the latest information. ARTL stock price has been found in the range of $1.26 to $1.62.
If compared to the average trading volume of 217.23K shares, ARTL reached a trading volume of 1625426 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Artelo Biosciences Inc. [ARTL]:
The Average True Range (ATR) for Artelo Biosciences Inc. is set at 0.18 The Price to Book ratio for the last quarter was 1.41, with the Price to Cash per share for the same quarter was set at 0.60.
Trading performance analysis for ARTL stock
Artelo Biosciences Inc. [ARTL] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 23.58. With this latest performance, ARTL shares gained by 24.59% in over the last four-week period, additionally sinking by -25.49% over the last 6 months – not to mention a rise of 38.18% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ARTL stock in for the last two-week period is set at 60.87, with the RSI for the last a single of trading hit 64.37, and the three-weeks RSI is set at 57.49 for Artelo Biosciences Inc. [ARTL]. The present Moving Average for the last 50 days of trading for this stock 1.2499, while it was recorded at 1.3320 for the last single week of trading, and 1.7858 for the last 200 days.
Artelo Biosciences Inc. [ARTL]: A deeper dive into fundamental analysis
Return on Total Capital for ARTL is now -120.52, given the latest momentum, and Return on Invested Capital for the company is -81.57. Return on Equity for this stock declined to -81.57, with Return on Assets sitting at -63.15.
Reflecting on the efficiency of the workforce at the company, Artelo Biosciences Inc. [ARTL] managed to generate an average of -$543,044 per employee.Artelo Biosciences Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 4.80 and a Current Ratio set at 4.80.
An analysis of insider ownership at Artelo Biosciences Inc. [ARTL]
There are presently around $0 million, or 0.40% of ARTL stock, in the hands of institutional investors. The top three institutional holders of ARTL stocks are: GOLDMAN SACHS GROUP INC with ownership of 14,223, which is approximately 0% of the company’s market cap and around 19.20% of the total institutional ownership; UBS GROUP AG, holding 799 shares of the stock with an approximate value of $1000.0 in ARTL stocks shares; and WELLS FARGO & COMPANY/MN, currently with $0.0 in ARTL stock with ownership of nearly New of the company’s market capitalization.
2 institutional holders increased their position in Artelo Biosciences Inc. [NASDAQ:ARTL] by around 815 shares. Additionally, 0 investors decreased positions by around 0 shares, while 1 investors held positions by with 14,223 shares. The mentioned changes placed institutional holdings at 15,038 shares, according to the latest SEC report filing. ARTL stock had 2 new institutional investments in for a total of 815 shares, while 0 institutional investors sold positions of 0 shares during the same period.